VMD Stock Overview
Provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for VMD from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Viemed Healthcare, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$7.98 |
| 52 Week High | US$10.44 |
| 52 Week Low | US$6.21 |
| Beta | 1.46 |
| 1 Month Change | -8.80% |
| 3 Month Change | 9.17% |
| 1 Year Change | -1.48% |
| 3 Year Change | 42.75% |
| 5 Year Change | 27.07% |
| Change since IPO | 344.92% |
Recent News & Updates
Recent updates
When Should You Buy Viemed Healthcare, Inc. (NASDAQ:VMD)?
Apr 11
These 4 Measures Indicate That Viemed Healthcare (NASDAQ:VMD) Is Using Debt Safely
Mar 07Viemed Healthcare: Comments On Q2 Earnings
Aug 25Viemed Healthcare Q2 2022 Earnings Preview
Aug 02Viemed Healthcare: New Bullish Trend Has Just Begun
Dec 29Viemed Healthcare, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 06Viemed Healthcare EPS misses by $0.01, revenue in-line
May 03Strong Execution By Insider-Owners Ensures Viemed's Growth
Jan 11Viemed Healthcare EPS misses by $0.02, beats on revenue
Nov 05Shareholder Returns
| VMD | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -8.7% | -4.1% | -2.4% |
| 1Y | -1.5% | -10.2% | 23.3% |
Return vs Industry: VMD exceeded the US Healthcare industry which returned -10.2% over the past year.
Return vs Market: VMD underperformed the US Market which returned 23.3% over the past year.
Price Volatility
| VMD volatility | |
|---|---|
| VMD Average Weekly Movement | 4.7% |
| Healthcare Industry Average Movement | 7.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: VMD has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: VMD's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 1,142 | Casey Hoyt | www.viemed.com |
Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices.
Viemed Healthcare, Inc. Fundamentals Summary
| VMD fundamental statistics | |
|---|---|
| Market cap | US$310.71m |
| Earnings (TTM) | US$10.43m |
| Revenue (TTM) | US$214.30m |
29.8x
P/E Ratio1.4x
P/S RatioIs VMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VMD income statement (TTM) | |
|---|---|
| Revenue | US$214.30m |
| Cost of Revenue | US$85.13m |
| Gross Profit | US$129.18m |
| Other Expenses | US$118.75m |
| Earnings | US$10.43m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.27 |
| Gross Margin | 60.28% |
| Net Profit Margin | 4.87% |
| Debt/Equity Ratio | 3.5% |
How did VMD perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 02:52 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Viemed Healthcare, Inc. is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Nick Corcoran | Acumen Capital Finance Partners Limited |
| Doug Cooper | Beacon Securities Limited |
| Vadim Merkulov | Freedom Broker |